ARTICLE | Clinical News
IPH4102: Phase I started
December 14, 2015 8:00 AM UTC
Innate began an open-label, international Phase I trial of IV IPH4102 in about 60 patients with KIR3dL 2-positive CTCL who received >=2 prior lines of therapy. The dose-escalation portion will evaluat...